According to a new market report published by Lucintel, the future of the metabolomics market looks promising with opportunities in various appliations, such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and personalized medicine. The global metabolomics market is expected to grow with a CAGR of 14% from 2020 to 2025. The major drivers for this market are increasing research and development activities in pharmaceutical and biotechnology and increasing prevalence of chronic diseases.
To download report brochure, please go to https://www.lucintel.com/metabolomics-market.aspx and click "download brochure" tab from the menu
Metabolomics is the systematic study of chemical processes involving metabolites, the small molecule substrates, intermediates, and products of metabolism. In this market, metabolomics instruments (separation tools and detection tools) and metabolomics bioinformatics tools and services are the major products and services. Lucintel forecasts that metabolomics instruments will remain the largest product and service segment over the forecast period, as they are mostly used in research activities.
Within this market, biomarker discovery will remain the largest application segment over the forecast period due to rising prevalance of chronic diseases, such as cancer and diabetes, and increasing acceptance of cancer diagnostic tests.
North America will remain the largest region over the forecast period due to high per capita healthcare expenditure and increasing adoption of healthcare technology.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of HPLC and UPLC technique for its most versatile separation method. Agilent Technologies, Bio- Rad Laboratories, Bruker Corporation, Danaher, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences, and Metabolon are among the major suppliers in the global metabolomics market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global metabolomics market by product and service, application, indication, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Metabolomics Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global metabolomics market by product and service, application, indication, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Metabolomics Instruments
Separation Tools
Detection Tools
Metabolomics Bioinformatic Tools and Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Personalized Medicine
Other Applications
By Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Other Indications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This more than 150-pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.